Literature DB >> 20017602

Extracellular/microenvironmental redox state.

Luksana Chaiswing1, Terry D Oberley.   

Abstract

Extracellular redox (reduction-oxidation) state is a factor that serves as an important regulator of cell-microenvironmental interactions and is determined by several known variables; including redox-modulating proteins that are located on the plasma membrane or outside of cells, extracellular thiol/disulfide couples, and reactive oxygen species (ROS)/reactive nitrogen species (RNS) that are capable of traveling across plasma membranes into the extracellular space. The extracellular redox state works in concert with the intracellular redox state to control both the influx and efflux of ROS/RNS that may serve to modulate redox signaling or to perturb normal cellular processes or both. Under physiologic conditions, the extracellular space is known to have a relatively more-oxidized redox state than the interior of the cell. During pathologic conditions, such as cancer, the extracellular redox state may be altered, causing specific proteins such as proteases, soluble factors, or the extracellular matrix to have altered functions or activities. Recent studies have strongly supported an important relation between the extracellular redox state and cancer cell aggressiveness. The purpose of this review is to identify redox buffer networks in extracellular spaces and to emphasize the possible roles of the extracellular redox state in cancer, knowledge that may contribute to potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20017602     DOI: 10.1089/ars.2009.3020

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  39 in total

Review 1.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

Review 2.  Redox metabolism and malignancy.

Authors:  Christina L Grek; Kenneth D Tew
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

3.  Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.

Authors:  Etienne Dardenne; Sandra Pierredon; Keltouma Driouch; Lise Gratadou; Magali Lacroix-Triki; Micaela Polay Espinoza; Eleonora Zonta; Sophie Germann; Hussein Mortada; Jean-Philippe Villemin; Martin Dutertre; Rosette Lidereau; Stéphan Vagner; Didier Auboeuf
Journal:  Nat Struct Mol Biol       Date:  2012-09-30       Impact factor: 15.369

Review 4.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

5.  Extracellular redox state shift: A novel approach to target prostate cancer invasion.

Authors:  Weixiong Zhong; Heidi L Weiss; Rani D Jayswal; Patrick J Hensley; Laura M Downes; Daret K St Clair; Luksana Chaiswing
Journal:  Free Radic Biol Med       Date:  2018-02-02       Impact factor: 7.376

Review 6.  Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.

Authors:  H Inoue; K Tani
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

Review 7.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

8.  Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice.

Authors:  Jin Oshikawa; Norifumi Urao; Ha Won Kim; Nihal Kaplan; Masooma Razvi; Ronald McKinney; Leslie B Poole; Tohru Fukai; Masuko Ushio-Fukai
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 9.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

10.  Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy.

Authors:  Levani Zandarashvili; Debashish Sahu; Kwanbok Lee; Yong Sun Lee; Pomila Singh; Krishna Rajarathnam; Junji Iwahara
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.